Int J Pediatr Otorhinolaryngol:影响小耳症和耳道闭锁治疗选择的社会经济和临床因素

2021-01-18 AlexYang MedSci原创

对小耳症和耳道闭锁的患者,有多种治疗传导性听力损失和耳廓重建的选择;然而,对影响治疗选择的因素知之甚少。最近,有研究人员回顾了小耳症/耳道闭锁患者的社会经济和临床数据,并评估了与国家数据的一致性,以及

对小耳症和耳道闭锁的患者,有多种治疗传导性听力损失和耳廓重建的选择;然而,对影响治疗选择的因素知之甚少。最近,有研究人员回顾了小耳症/耳道闭锁患者的社会经济和临床数据,并评估了与国家数据的一致性,以及这些因素是否影响治疗决策

研究人员回顾性地审查了2008年至2018年在一家高等教育儿童医院的小耳症和闭锁多学科诊所(MDC)评估的患者。结果包括与听力手术和框架手术相关的人口学、社会经济和临床因素。研究共有373名患者在小耳症MDC就诊:193名(51.7%)为男性,187名(50.1%)为西班牙裔,23名(6.2%)确定为亚裔。267名(75.6%)患者接受了非手术骨导助听器(BCHD);在年轻时安装与更好的非手术BCHD依从性有关。根据年龄和适当的随访,研究人员对符合手术条件的患者进行了多变量分析。70名(18.8%)患者进行了骨结合BCHD的置入;不一致的非手术BCHD依从性降低了进行骨结合BCHD置入的几率。60名(16.1%)患者接受了框架手术进行外部重建。骨结合BCHD的置入是唯一与进行框架手术相关的因素。其他评估的人口学和社会经济因素与手术干预的选择没有统计学意义。

最后,研究人员指出,在较小的年龄安装非手术BCHD与较高的非手术BCHD依从性有关,反过来又与患者和家庭进行骨整合BCHD和框架手术有关

原始出处:

Saied Ghadersohi , Salina Haville , Megan Hedman et al. Socioeconomic and clinical factors influencing treatment selection in microtia and aural atresia. Int J Pediatr Otorhinolaryngol. Dec 2020

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1639703, encodeId=2f231639e03fc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 20 02:57:09 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689780, encodeId=a22f1689e80d3, content=<a href='/topic/show?id=2f934e098a3' target=_blank style='color:#2F92EE;'>#小耳症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47098, encryptionId=2f934e098a3, topicName=小耳症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45cb28872848, createdName=12498dabm86暂无昵称, createdTime=Wed Oct 20 01:57:09 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924502, encodeId=f8001924502d4, content=<a href='/topic/show?id=a7f2e3997c4' target=_blank style='color:#2F92EE;'>#社会经济#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73997, encryptionId=a7f2e3997c4, topicName=社会经济)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Mon Feb 01 13:57:09 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772739, encodeId=1c851e7273948, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Thu Mar 25 09:57:09 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728784, encodeId=c5801e28784b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Oct 24 13:57:09 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007583, encodeId=fd73200e58372, content=<a href='/topic/show?id=1ec222e50e6' target=_blank style='color:#2F92EE;'>#临床因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22750, encryptionId=1ec222e50e6, topicName=临床因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu May 13 05:57:09 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936534, encodeId=011f193653496, content=<a href='/topic/show?id=ac508051935' target=_blank style='color:#2F92EE;'>#耳道闭锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80519, encryptionId=ac508051935, topicName=耳道闭锁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Aug 14 07:57:09 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617038, encodeId=8d4a161e03846, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Wed Jan 20 13:57:09 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1639703, encodeId=2f231639e03fc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 20 02:57:09 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689780, encodeId=a22f1689e80d3, content=<a href='/topic/show?id=2f934e098a3' target=_blank style='color:#2F92EE;'>#小耳症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47098, encryptionId=2f934e098a3, topicName=小耳症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45cb28872848, createdName=12498dabm86暂无昵称, createdTime=Wed Oct 20 01:57:09 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924502, encodeId=f8001924502d4, content=<a href='/topic/show?id=a7f2e3997c4' target=_blank style='color:#2F92EE;'>#社会经济#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73997, encryptionId=a7f2e3997c4, topicName=社会经济)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Mon Feb 01 13:57:09 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772739, encodeId=1c851e7273948, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Thu Mar 25 09:57:09 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728784, encodeId=c5801e28784b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Oct 24 13:57:09 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007583, encodeId=fd73200e58372, content=<a href='/topic/show?id=1ec222e50e6' target=_blank style='color:#2F92EE;'>#临床因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22750, encryptionId=1ec222e50e6, topicName=临床因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu May 13 05:57:09 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936534, encodeId=011f193653496, content=<a href='/topic/show?id=ac508051935' target=_blank style='color:#2F92EE;'>#耳道闭锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80519, encryptionId=ac508051935, topicName=耳道闭锁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Aug 14 07:57:09 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617038, encodeId=8d4a161e03846, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Wed Jan 20 13:57:09 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1639703, encodeId=2f231639e03fc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 20 02:57:09 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689780, encodeId=a22f1689e80d3, content=<a href='/topic/show?id=2f934e098a3' target=_blank style='color:#2F92EE;'>#小耳症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47098, encryptionId=2f934e098a3, topicName=小耳症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45cb28872848, createdName=12498dabm86暂无昵称, createdTime=Wed Oct 20 01:57:09 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924502, encodeId=f8001924502d4, content=<a href='/topic/show?id=a7f2e3997c4' target=_blank style='color:#2F92EE;'>#社会经济#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73997, encryptionId=a7f2e3997c4, topicName=社会经济)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Mon Feb 01 13:57:09 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772739, encodeId=1c851e7273948, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Thu Mar 25 09:57:09 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728784, encodeId=c5801e28784b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Oct 24 13:57:09 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007583, encodeId=fd73200e58372, content=<a href='/topic/show?id=1ec222e50e6' target=_blank style='color:#2F92EE;'>#临床因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22750, encryptionId=1ec222e50e6, topicName=临床因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu May 13 05:57:09 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936534, encodeId=011f193653496, content=<a href='/topic/show?id=ac508051935' target=_blank style='color:#2F92EE;'>#耳道闭锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80519, encryptionId=ac508051935, topicName=耳道闭锁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Aug 14 07:57:09 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617038, encodeId=8d4a161e03846, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Wed Jan 20 13:57:09 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1639703, encodeId=2f231639e03fc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 20 02:57:09 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689780, encodeId=a22f1689e80d3, content=<a href='/topic/show?id=2f934e098a3' target=_blank style='color:#2F92EE;'>#小耳症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47098, encryptionId=2f934e098a3, topicName=小耳症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45cb28872848, createdName=12498dabm86暂无昵称, createdTime=Wed Oct 20 01:57:09 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924502, encodeId=f8001924502d4, content=<a href='/topic/show?id=a7f2e3997c4' target=_blank style='color:#2F92EE;'>#社会经济#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73997, encryptionId=a7f2e3997c4, topicName=社会经济)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Mon Feb 01 13:57:09 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772739, encodeId=1c851e7273948, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Thu Mar 25 09:57:09 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728784, encodeId=c5801e28784b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Oct 24 13:57:09 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007583, encodeId=fd73200e58372, content=<a href='/topic/show?id=1ec222e50e6' target=_blank style='color:#2F92EE;'>#临床因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22750, encryptionId=1ec222e50e6, topicName=临床因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu May 13 05:57:09 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936534, encodeId=011f193653496, content=<a href='/topic/show?id=ac508051935' target=_blank style='color:#2F92EE;'>#耳道闭锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80519, encryptionId=ac508051935, topicName=耳道闭锁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Aug 14 07:57:09 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617038, encodeId=8d4a161e03846, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Wed Jan 20 13:57:09 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1639703, encodeId=2f231639e03fc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 20 02:57:09 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689780, encodeId=a22f1689e80d3, content=<a href='/topic/show?id=2f934e098a3' target=_blank style='color:#2F92EE;'>#小耳症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47098, encryptionId=2f934e098a3, topicName=小耳症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45cb28872848, createdName=12498dabm86暂无昵称, createdTime=Wed Oct 20 01:57:09 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924502, encodeId=f8001924502d4, content=<a href='/topic/show?id=a7f2e3997c4' target=_blank style='color:#2F92EE;'>#社会经济#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73997, encryptionId=a7f2e3997c4, topicName=社会经济)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Mon Feb 01 13:57:09 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772739, encodeId=1c851e7273948, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Thu Mar 25 09:57:09 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728784, encodeId=c5801e28784b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Oct 24 13:57:09 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007583, encodeId=fd73200e58372, content=<a href='/topic/show?id=1ec222e50e6' target=_blank style='color:#2F92EE;'>#临床因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22750, encryptionId=1ec222e50e6, topicName=临床因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu May 13 05:57:09 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936534, encodeId=011f193653496, content=<a href='/topic/show?id=ac508051935' target=_blank style='color:#2F92EE;'>#耳道闭锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80519, encryptionId=ac508051935, topicName=耳道闭锁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Aug 14 07:57:09 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617038, encodeId=8d4a161e03846, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Wed Jan 20 13:57:09 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-10-24 feather89
  6. [GetPortalCommentsPageByObjectIdResponse(id=1639703, encodeId=2f231639e03fc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 20 02:57:09 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689780, encodeId=a22f1689e80d3, content=<a href='/topic/show?id=2f934e098a3' target=_blank style='color:#2F92EE;'>#小耳症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47098, encryptionId=2f934e098a3, topicName=小耳症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45cb28872848, createdName=12498dabm86暂无昵称, createdTime=Wed Oct 20 01:57:09 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924502, encodeId=f8001924502d4, content=<a href='/topic/show?id=a7f2e3997c4' target=_blank style='color:#2F92EE;'>#社会经济#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73997, encryptionId=a7f2e3997c4, topicName=社会经济)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Mon Feb 01 13:57:09 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772739, encodeId=1c851e7273948, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Thu Mar 25 09:57:09 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728784, encodeId=c5801e28784b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Oct 24 13:57:09 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007583, encodeId=fd73200e58372, content=<a href='/topic/show?id=1ec222e50e6' target=_blank style='color:#2F92EE;'>#临床因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22750, encryptionId=1ec222e50e6, topicName=临床因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu May 13 05:57:09 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936534, encodeId=011f193653496, content=<a href='/topic/show?id=ac508051935' target=_blank style='color:#2F92EE;'>#耳道闭锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80519, encryptionId=ac508051935, topicName=耳道闭锁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Aug 14 07:57:09 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617038, encodeId=8d4a161e03846, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Wed Jan 20 13:57:09 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-05-13 howi
  7. [GetPortalCommentsPageByObjectIdResponse(id=1639703, encodeId=2f231639e03fc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 20 02:57:09 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689780, encodeId=a22f1689e80d3, content=<a href='/topic/show?id=2f934e098a3' target=_blank style='color:#2F92EE;'>#小耳症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47098, encryptionId=2f934e098a3, topicName=小耳症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45cb28872848, createdName=12498dabm86暂无昵称, createdTime=Wed Oct 20 01:57:09 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924502, encodeId=f8001924502d4, content=<a href='/topic/show?id=a7f2e3997c4' target=_blank style='color:#2F92EE;'>#社会经济#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73997, encryptionId=a7f2e3997c4, topicName=社会经济)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Mon Feb 01 13:57:09 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772739, encodeId=1c851e7273948, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Thu Mar 25 09:57:09 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728784, encodeId=c5801e28784b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Oct 24 13:57:09 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007583, encodeId=fd73200e58372, content=<a href='/topic/show?id=1ec222e50e6' target=_blank style='color:#2F92EE;'>#临床因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22750, encryptionId=1ec222e50e6, topicName=临床因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu May 13 05:57:09 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936534, encodeId=011f193653496, content=<a href='/topic/show?id=ac508051935' target=_blank style='color:#2F92EE;'>#耳道闭锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80519, encryptionId=ac508051935, topicName=耳道闭锁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Aug 14 07:57:09 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617038, encodeId=8d4a161e03846, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Wed Jan 20 13:57:09 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1639703, encodeId=2f231639e03fc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Jul 20 02:57:09 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689780, encodeId=a22f1689e80d3, content=<a href='/topic/show?id=2f934e098a3' target=_blank style='color:#2F92EE;'>#小耳症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47098, encryptionId=2f934e098a3, topicName=小耳症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45cb28872848, createdName=12498dabm86暂无昵称, createdTime=Wed Oct 20 01:57:09 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924502, encodeId=f8001924502d4, content=<a href='/topic/show?id=a7f2e3997c4' target=_blank style='color:#2F92EE;'>#社会经济#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73997, encryptionId=a7f2e3997c4, topicName=社会经济)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Mon Feb 01 13:57:09 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772739, encodeId=1c851e7273948, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Thu Mar 25 09:57:09 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728784, encodeId=c5801e28784b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Oct 24 13:57:09 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007583, encodeId=fd73200e58372, content=<a href='/topic/show?id=1ec222e50e6' target=_blank style='color:#2F92EE;'>#临床因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22750, encryptionId=1ec222e50e6, topicName=临床因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu May 13 05:57:09 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936534, encodeId=011f193653496, content=<a href='/topic/show?id=ac508051935' target=_blank style='color:#2F92EE;'>#耳道闭锁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80519, encryptionId=ac508051935, topicName=耳道闭锁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3e72500135, createdName=jingyanzhu715_39486101, createdTime=Sat Aug 14 07:57:09 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617038, encodeId=8d4a161e03846, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Wed Jan 20 13:57:09 CST 2021, time=2021-01-20, status=1, ipAttribution=)]

相关资讯

Crit Care:革兰染色结果对呼吸机相关性肺炎患者初始治疗选择的影响!

基于革兰氏染色结果的抗菌治疗可能会限制广谱抗菌药物的使用,但不会增加治疗失败的风险。

Clin Otolaryngol:单侧耳聋和不对称听力损失患者的治疗选择

最近,有研究人员阐述了一个单侧耳聋(SSD)和非对称性听力损失(AHL)患者队列的治疗选择,并评估了治疗试验的可靠性。

艾立布林是晚期乳腺癌蒽环紫杉类治疗后化疗的重要治疗选择

随着化疗药物的研发,蒽环崛起,紫杉风靡,多项临床试验证实化疗是乳腺癌治疗的基础。蒽环紫杉之后20年,化疗领域鲜见单药OS获益的药物,且蒽环紫杉应用后化疗方案如何选择亦无明确标准。作用机制不同于蒽环、紫杉等化疗药物的微管动力学抑制剂艾立布林(Eribulin)已经在美国、欧洲、日本等全球多个国家和地区获批用于晚期乳腺癌治疗,成为蒽环、紫杉应用后的重要选择。近期,来自欧洲的一项大样本量的相关真实世界研

Justin Stebbing教授分享肺癌异质性和治疗选择

“2019全国肺癌大会”在上海隆重召开,本次会议由中国抗癌协会肺癌专业委员会主办、上海交通大学附属胸科医院承办,围绕肺癌的手术治疗、放疗、精准治疗、免疫治疗及多学科协作等议题展开了深入的讨论。在6月22日国际专场上,来自英国Hammer Smith医院的Justin Stebbing教授带来了“肺癌异质性和治疗选择”的主题演讲,有幸邀请到Justin Stebbing教授就这一话题和免疫治疗热点问

绝经前乳腺癌的治疗选择

陈占红主任医师,浙江省肿瘤医院乳腺内科主任医师,中国抗癌协会乳腺癌专业委员会青年委员会委员,中国临床肿瘤学会(CSCO)乳腺癌专家委员会委员 中国抗癌协会第一届整合肿瘤心脏病血分会委员 中国宋庆龄基金会肿瘤医疗及产学研联盟 浙江省抗癌协会乳腺癌专业委员会委员 浙江省抗癌协会肿瘤内科专业委员会委员 浙江省免疫学会肿瘤免疫与生物治疗专业委员会副主任委员 浙江省细胞生物学会理事兼医学细胞生物学会专业委员

韩国宏教授:中期肝癌的治疗选择及疗效分析

中期肝癌具有较大的异质性,患者对不同治疗方案的预后存在较大差异。如何为患者选择适合的治疗方案是目前迫切需要解决的难题。在本期“公开课”中,空军军医大学西京消化病医院、国家消化系疾病临床医学研究中心韩国宏教授通过对现有中期肝癌的治疗选择进行比较和分析,不仅给出了目前这一人群的主流治疗建议,同时也提出了进一步提高中期肝癌疗效的多个热点研究方向。